Fundraising Fox

Alcyone Therapeutics

Lowell, US · Founded 2010 · Delaware corporation · 1 known investors

Healthtech

Founders & leadership

Alcyone Therapeutics was founded in 2010 by PJ Anand.

PA
PJ AnandFounder

Board

ED
Edgar D. JannottaBoard director
EJ
Edgar Jannotta, Jr.Board director
DD
David DonabedianBoard directorPartner, NewCo Formation at Longwood Fund
NR
Norbert RiedelBoard director
SO
Stephen OesterleBoard director
RU
Richard UptonBoard director
CD
Cameron DurrantBoard director

Investors · 1

Longwood FundreportedBostonvia David Donabedian · board

Reported raises · per SEC filings

Form D private placements

$92.2M disclosed across 9 rounds · 2011–2023

▶$19MraisedJan 2025 · 25 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Edgar D. JannottaDirector
  • David DonabedianDirector
  • Norbert RiedelDirector
  • Stephen OesterleDirector
  • PJ AnandExecutive Officer, Director
  • Richard UptonDirector
  • Cameron DurrantDirector
Offering amount
$31.6M
Amount sold
$19M
Finders' fees
$252.8K
Placement agents
Arcadia Securities, LLC
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$37.1MraisedJun 2021 · 31 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Piratip PratumsuwanDirector
  • David DonabedianDirector
  • Cameron DurrantDirector
  • PJ AnandExecutive Officer, Director
  • Edgar Jannotta, Jr.Director
  • Richard UptonDirector
  • Stephen OesterleDirector
Offering amount
$37.1M
Amount sold
$37.1M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.6MraisedSep 2020 · 28 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • PJ AnandExecutive Officer, Director
  • Cameron DurrantDirector
  • Richard UptonDirector
  • Edgar Jannotta, Jr.Director
  • David DonabedianDirector
  • Stephen OesterleDirector
Offering amount
$19.5M
Amount sold
$17.6M
First sale
Aug 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedJul 2019 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David DonabedianDirector
  • Edgar Jannotta, Jr.Director
  • Stephen OesterleDirector
  • Cameron DurrantDirector
  • Richard UptonDirector
  • PJ AnandExecutive Officer, Director
Offering amount
$3M
Amount sold
$2.2M
First sale
Jun 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.6MraisedApr 2019 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • PJ AnandExecutive Officer, Director
  • Stephen OesterleDirector
  • Cameron DurrantDirector
  • David DonabedianDirector
  • Edgar Jannotta, Jr.Director
  • Richard UptonDirector
Offering amount
$1.6M
Amount sold
$1.6M
First sale
Mar 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.1MraisedJan 2018 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David DonabedianDirector
  • PJ AnandExecutive Officer, Director
  • Richard UptonDirector
  • Stephen OesterleDirector
  • Cameron DurrantDirector
  • Edgar Jannotta, Jr.Director
Offering amount
$5.1M
Amount sold
$5.1M
First sale
Jan 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.6MraisedDec 2015 · 20 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • PJ AnandExecutive Officer, Director
  • David DonabedianDirector
  • Richard UptonDirector
  • Edgar Jannotta, Jr.Director
  • Cameron DurrantDirector
Offering amount
$3.7M
Amount sold
$3.6M
First sale
Dec 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedJan 2014 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • PJ AnandExecutive Officer, Director
  • Edgard Jannotta, Jr.Director
  • Richard UptonDirector
  • David DonabedianDirector
  • Cameron DurrantDirector
Offering amount
$4M
Amount sold
$4M
First sale
Dec 2013
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Alcyone Therapeutics Announces Strategic Financing on Heels of Expanded Collaboration with Nationwide Children’s Hospital - Global Genesglobalgenes.org · Apr 2025Alcyone Therapeutics Announces Strategic Financing to Advance an Expanded Pipeline of Pediatric-Focused Precision Therapeutics for Severe Neurological Diseasesprnewswire.com · Apr 2025Alcyone Therapeutics Launches to Advance Next-Generation Gene Therapies for CNS Disorders - BioSpacebiospace.com · Jun 2021Alcyone Therapeutics Launches to Advance Next-Generation Gene Therapies for CNS Disordersprnewswire.com · Jun 2021Alcyone Therapeutics picks up $23M in hopes of being a star in treating CNS disorders | Fierce Biotechfiercebiotech.com · Jun 2021

Frequently asked questions

Who founded Alcyone Therapeutics?
Alcyone Therapeutics was founded by PJ Anand in 2010.
Who are Alcyone Therapeutics's investors?
Alcyone Therapeutics's investors include Longwood Fund.
How much funding has Alcyone Therapeutics raised?
Alcyone Therapeutics has disclosed $92.2M raised across 9 rounds.
Where is Alcyone Therapeutics headquartered?
Alcyone Therapeutics is headquartered in Lowell, US.